Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track focuses on the latest developments in clinical neurology, emphasizing innovative diagnostic and therapeutic approaches. Participants will explore case studies and emerging trends that are shaping the future of neurological practice.
This session will delve into the multifaceted nature of cognitive disorders and dementia, examining recent research findings and clinical implications. Experts will discuss diagnostic challenges and therapeutic strategies to enhance patient outcomes.
This track addresses the ethical dilemmas faced by neurologists in clinical practice and research. Discussions will include informed consent, patient autonomy, and the implications of emerging technologies in neurology.
This session will explore the role of genetics in the etiology and progression of various neurological disorders. Researchers will present findings on genetic markers and their potential for personalized medicine in neurology.
This track will highlight the latest advancements in functional neurosurgery, including techniques for treating movement disorders and epilepsy. Participants will gain insights into surgical outcomes and patient selection criteria.
This session will investigate the role of neuroinflammation in the pathophysiology of central nervous system disorders. Researchers will present data linking inflammatory processes to cognitive decline and neurodegeneration.
This track will focus on the latest research and clinical practices in vascular neurology, including stroke prevention and management. Experts will discuss novel therapies and the importance of multidisciplinary approaches in patient care.
This session will cover advancements in pharmacological treatments for central nervous system disorders, emphasizing novel drug development and therapeutic strategies. Participants will discuss the implications of pharmacogenomics in clinical practice.
This track will explore the underlying neurobiological mechanisms that contribute to cognitive function and dysfunction. Researchers will present findings from neuroimaging studies and animal models that shed light on cognitive processes.
This session will focus on the design, execution, and analysis of clinical trials in neurology. Participants will discuss best practices and regulatory considerations for conducting research in this complex field.
This track will provide a historical perspective on the evolution of neurology as a discipline, highlighting key milestones and influential figures. Discussions will reflect on how historical insights can inform contemporary practices and future directions in the field.